Evidence map›Paper›PMID 27195057›Full record

ArticleThe World Allergy Organization journal2016

Insights, attitudes, and perceptions about asthma and its treatment: a multinational survey of patients from Europe and Canada.

Joaquin Sastre, Leonardo M Fabbri, David Price, Hans Ulrich Wahn, Jean Bousquet, James E Fish, Kevin Murphy, Malcolm R Sears

Open access · goldAbstract read
In one paragraph

Article in The World Allergy Organization journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Observational
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Estimates of the Global Burden of AmbientEnvironmental health perspectives · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 7 countries.

Joaquin SastreFundacion Jimenez Diaz, Avenida Reyes Católicos 2, Madrid, 28040 Spain.
Leonardo M FabbriDepartment of Oncology Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Via Del Pozzo 71, Modena, I-41124 Italy.
David PriceDivision of Applied Health Sciences, University of Aberdeen, Polwarth Building, Aberdeen, AB25 2ZD UK.
Hans Ulrich WahnDepartment of Pediatric Pneumology and Immunology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Augustenburger Platz 1, Berlin, 13353 Germany.
Jean BousquetService des Maladies Respiratoires, Hopital Arnaud de Villeneuve, Montpellier-Cedex, 34059 France.
James E FishMerck & Co., Inc., 1526 Monticello Drive, Gladwyne, PA 19035 USA.
Kevin MurphyBoystown National Research Hospital, 14080 Hospital Road, Boys Town, NE 68010 USA.
Malcolm R SearsFirestone Institute for Respiratory Health, McMaster University and St. Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, ON L8N 4A6 Canada.
Boys Town National Research Hospital · USCharité - Universitätsmedizin Berlin · DEHôpital Arnaud de Villeneuve · FRHospital Universitario Fundación Jiménez Díaz · ESMcMaster University · CAMerck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Aberdeen · GBUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma surveys completed within the past 10 years in the Americas and the Asia-Pacific region have shown significant underassessment of asthma severity in addition to undertreatment of asthma and have suggested the need to improve long-term asthma management. In this study, we examined the frequency of asthma symptoms and severe episodes, patients' perceived asthma control, and use of asthma medications in Europe and Canada.

methodsThe Asthma Insight and Management survey (54 questions) was conducted in Europe (Germany, Italy, Spain and the United Kingdom) and Canada from June 14 through July 28, 2010. Telephone interviews were conducted with randomly screened patients or parents of adolescents (aged 12-17 years) with asthma; patients younger than 12 years of age were excluded from the survey. Responses were reported separately for each country and in total for all five countries.

resultsSeventy-five thousand three hundered thirty-five households were screened, and 2003 patients were interviewed. The survey respondents represented a wide range of severity. Overall, 26 % of patients reported symptoms daily or most days over the past 4 weeks, but most patients (81 %) perceived their asthma to be well or completely controlled. Over the past year, 41 % of patients had episodes of frequent/severe symptoms, and 50 % reported acute treatment (e.g. hospitalization, emergency visit, unscheduled physician visit) for asthma. Across countries, 52 % of patients reported taking controller medication every day over the past year, 27 % reported not taking any controller medication, and 14 % reported stopping controller treatment for 3 months or longer the last time they stopped. Many patients considered asthma well controlled if each year they had only two urgent doctor visits (50 %), three or four exacerbations (60 %), and/or one emergency room visit (41 %). DISCUSSION: This is the largest survey of patients with asthma in Europe and Canada in more than a decade.

conclusionIn 2010, many surveyed patients in Europe and Canada reported features indicating uncontrolled asthma, yet the majority believed they were well controlled, indicating that they had low expectations of long-term asthma management. Use of controller medications was substantially less than recommended in treatment guidelines.

Indexed as

AsthmaCanadaController medicationsEuropeManagementSurveySymptoms

Identifiers

PMID27195057
PMCPMC4855503
OpenAlexW2318274012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.